| Patent | Date |
|---|
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 11,116,765 - Gonda , et al. September 14, 2 | 2021-09-14 |
Concentrated, inhalable ciprofloxacin formulation
Grant 11,026,941 - Cipolla , et al. June 8, 2 | 2021-06-08 |
Liposomal Anti-infective Formulations To Inhibit Non-tuberculous Mycobacteria (ntm) Microaggregate Formation And Establishment Of Ntm Biofilm
App 20210007985 - GONDA; Igor ; et al. | 2021-01-14 |
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20200323845 - Gonda; Igor ; et al. | 2020-10-15 |
pH-Modulated Formulations for Pulmonary Delivery
App 20200297722 - Cipolla; David C. ; et al. | 2020-09-24 |
Concentrated, Inhalable Ciprofloxacin Formulation
App 20190388416 - CIPOLLA; DAVID C. ; et al. | 2019-12-26 |
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20190328731 - GONDA; Igor ; et al. | 2019-10-31 |
Concentrated, inhalable ciprofloxacin formulation
Grant 10,420,765 - Cipolla , et al. Sept | 2019-09-24 |
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 10,376,508 - Gonda , et al. A | 2019-08-13 |
Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
Grant 9,987,227 - Cipolla , et al. June 5, 2 | 2018-06-05 |
Liposomal formulations that form drug nanocrystals after freeze-thaw
Grant 9,968,555 - Cipolla , et al. May 15, 2 | 2018-05-15 |
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20180092912 - GONDA; Igor ; et al. | 2018-04-05 |
Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals
Grant 9,844,548 - Gonda , et al. December 19, 2 | 2017-12-19 |
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20170071934 - GONDA; Igor ; et al. | 2017-03-16 |
Concentrated, Inhalable Ciprofloxacin Formulation
App 20170035753 - CIPOLLA; DAVID C. ; et al. | 2017-02-09 |
Concentrated, inhalable ciprofloxacin formulation
Grant 9,545,401 - Cipolla , et al. January 17, 2 | 2017-01-17 |
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria
Grant 9,532,986 - Gonda , et al. January 3, 2 | 2017-01-03 |
pH-MODULATED FORMULATIONS FOR PULMONARY DELIVERY
App 20160331744 - CIPOLLA; David C. ; et al. | 2016-11-17 |
Nanocrystals Formed In A Microenvironment
App 20160120806 - CIPOLLA; David C. ; et al. | 2016-05-05 |
Concentrated, inhalable antibiotic formulation
Grant 9,259,424 - Cipolla , et al. February 16, 2 | 2016-02-16 |
Liposomal Ciprofloxacin Formulations With Activity Against Non-tuberculous Mycobacteria
App 20150283133 - GONDA; Igor ; et al. | 2015-10-08 |
Novel Liposomal Formulations That Form Drug Nanocrystals After Freeze-thaw
App 20150283076 - CIPOLLA; David C. ; et al. | 2015-10-08 |
Concentrated, Inhalable Antibiotic Formulation
App 20150202201 - CIPOLLA; DAVID C. ; et al. | 2015-07-23 |
Concentrated, inhalable antibiotic formulation
Grant 9,078,897 - Cipolla , et al. July 14, 2 | 2015-07-14 |
Concentrated, inhalable antibiotic formulation
Grant 9,028,864 - Cipolla , et al. May 12, 2 | 2015-05-12 |
Inhaled Surfactant-modified Liposomal Formulations Providing Both An Immediate And Sustained Release Profile
App 20150110855 - CIPOLLA; David C. ; et al. | 2015-04-23 |
Concentrated, Inhalable Antibiotic Formulation
App 20150071992 - CIPOLLA; DAVID C. ; et al. | 2015-03-12 |
Dual action, inhaled formulations providing both an immediate and sustained release profile
Grant 8,414,915 - Cipolla , et al. April 9, 2 | 2013-04-09 |
Dual Action, Inhaled Formulations Providing Both An Immediate And Sustained Release Profile
App 20120282328 - CIPOLLA; DAVID C. ; et al. | 2012-11-08 |
Dual Action, Inhaled Formulations Providing Both An Immediate And Sustained Release Profile
App 20120244206 - Cipolla; David C. ; et al. | 2012-09-27 |
Dual action, inhaled formulations providing both an immediate and sustained release profile
Grant 8,268,347 - Cipolla , et al. September 18, 2 | 2012-09-18 |
Deep Lung Pulmonary Delivery Of Treprostinil
App 20120177693 - Cipolla; David C. ; et al. | 2012-07-12 |
Dual action, inhaled formulations providing both an immediate and sustained release profile
Grant 8,119,156 - Cipolla , et al. February 21, 2 | 2012-02-21 |
Dual action, inhaled formulations providing both an immediate and sustained release profile
Grant 8,071,127 - Cipolla , et al. December 6, 2 | 2011-12-06 |
Concentrated, Inhalable Ciprofloxacin Formulation
App 20110150983 - CIPOLLA; DAVID C. ; et al. | 2011-06-23 |
Processes For Taste-masking Of Inhaled Formulations
App 20110104259 - Schuster; Jeffrey A. ; et al. | 2011-05-05 |
Concentrated, Inhalable Antibiotic Formulation
App 20110064796 - Cipolla; David C. ; et al. | 2011-03-17 |
Ph-modulated Formulations For Pulmonary Delivery
App 20100209538 - Cipolla; David C. ; et al. | 2010-08-19 |
Dual Action, Inhaled Formulations Providing Both An Immediate And Sustained Release Profile
App 20090274754 - Cipolla; David C. ; et al. | 2009-11-05 |
Dual Action, Inhaled Formulations Providing Both An Immediate And Sustained Release Profile
App 20090269396 - Cipolla; David C. ; et al. | 2009-10-29 |
Processes For Taste-masking Of Inhaled Formulations
App 20080138397 - Schuster; Jeffrey A. ; et al. | 2008-06-12 |
Human relaxin formulation
Grant 5,945,402 - Cipolla , et al. August 31, 1 | 1999-08-31 |
| 